Olav Andreas Hopland
Papers
1
Total Citations
3
H-Index
1
About
Olav Andreas Hopland is a urologic surgeon whose research focuses on the management of recurrent prostate cancer, particularly through advanced robotic surgical techniques. His major contribution lies in evaluating the efficacy and safety of robot-assisted salvage pelvic lymph node dissection (sPLND) for patients with locoregional recurrence after radical prostatectomy. In his most-cited work, a single-institution study, he assessed treatment response—defined as a PSA drop below 0.2 ng/ml—alongside the need for additional therapy and complication rates. This research addresses a critical gap in managing biochemical recurrence, offering insights into a minimally invasive salvage option. While his citation count is still growing, his work is notable for its direct clinical relevance, providing evidence that can guide surgical decision-making in a challenging patient population. Hopland’s contributions are particularly valuable for urologists and oncologists seeking to optimize outcomes after primary treatment failure, and his ongoing work promises to further refine robotic approaches in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1